<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00855829</url>
  </required_header>
  <id_info>
    <org_study_id>galmedics-HMO-CTIL</org_study_id>
    <nct_id>NCT00855829</nct_id>
  </id_info>
  <brief_title>A Feasibility Study Designed to Assess the Efficacy of the ActiLady Device in Adult Female Subjects With Dysmenorrhea</brief_title>
  <official_title>A Single-Center, Randomized, Controlled, Double-Blind Feasibility Study Designed to Assess the Safety Performance of ActiLady Prototype in Adult Female Subjects With Dysmenorrhea.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      ActiLady refers is employing targeted pressure waves, with the goal of reducing the pain
      associated with menstruation (clinically known as dysmenorrhea).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the safety of a novel method and device called ActiLady.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>* Evaluate the pain-reducing effect of ActiLady on dysmenorrhea. * Study the relationship between menses flux and dysmenorrhea. [Time Frame: 6 months] [Designated as safety issue: No ] * Optimize treatment procedure and wave form.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Dysmenorrhea</condition>
  <arm_group>
    <arm_group_label>Miniature Actilady device active</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>one miniature Actilady device tested for all patients during a 4 months period. The device is active in 3 months out of the 4, and the patients are blinded to the action of the device (sham comparator).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Miniature Actilady device not active</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham Comparator: one miniature Actilady device tested for all patients during a 4 months period. The device is active in 3 months out of the 4, and the patients are blinded to the action of the device (sham comparator).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Miniature Actilady device active</intervention_name>
    <description>Devices: Targeted pressure waves are created by two kind of methods ActiLady).
The effect of the waves used will be examined by the use of a silicon tube or polyvinyl chloride (PVC) tube which is inserted into the vaginal cavity. The other end of the tube will be connected to an &quot;off the shelf&quot; pressure waves generator and controller.
Self manufactured device inserted into the vaginal cavity and creating subsound pressure waves.</description>
    <arm_group_label>Miniature Actilady device active</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Miniature Actilady device not active</intervention_name>
    <description>Devices: Targeted pressure waves are created by two kind of methods ActiLady).
The effect of the waves used will be examined by the use of a silicon tube or polyvinyl chloride (PVC) tube which is inserted into the vaginal cavity. The other end of the tube will be connected to an &quot;off the shelf&quot; pressure waves generator and controller.
Self manufactured device inserted into the vaginal cavity and creating subsound pressure waves.</description>
    <arm_group_label>Miniature Actilady device not active</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women aged 18-35 years

          2. Regular menstrual cycles (26-35 days); average duration of menstruation â‰¥5 days for
             the 4 months preceding the beginning of the trial.

          3. Dysmenorrhea pain score &gt;50mm on a 100mm visual analog scale (VAS) for the maximum
             abdominal pain

          4. Analgesic use during every menstrual cycle

          5. Non-pregnant, with no intentions to get pregnant during the clinical trial

          6. Agrees not to use oral contraceptives or an intrauterine device (IUD) during the trial
             period

          7. Agrees not to use analgesics, except during permitted period (16:00-04:00 the next
             day, daily)

          8. Consents to the use of pads or other vaginal devices throughout the trial period

          9. Subject is able to comply with all the requirements of the study and agrees to
             participate in all the activities of the study

         10. Signed written informed consent form (ICF) to participate in the study

        Exclusion Criteria:

          1. Pregnant or lactating women

          2. Used hormonal and/or oral contraceptives in the preceding 4 months

          3. Use of an IUD in the preceding 4 months

          4. Previous diagnosis of secondary dysmenorrhea

          5. Urinary incontinence

          6. Duration of menstruation is &lt;5 days

          7. Subjects with a known sensitivity to mechanical vibrations and/or silicone

          8. Participation in current or recent clinical trial within 30 days prior to baseline
             visit
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2009</study_first_submitted>
  <study_first_submitted_qc>March 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2009</study_first_posted>
  <last_update_submitted>November 10, 2013</last_update_submitted>
  <last_update_submitted_qc>November 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hadassah Medical Organization</investigator_affiliation>
    <investigator_full_name>Ezra Yosi</investigator_full_name>
    <investigator_title>Prof. Yossi Ezra</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dysmenorrhea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

